2015
DOI: 10.1002/14651858.cd002919.pub3
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults

Abstract: Analysis 1.2. Comparison 1 SSRI or SNRI versus placebo, Outcome 2 Withdrawals-any reason.. .. .. .. Analysis 1.3. Comparison 1 SSRI or SNRI versus placebo, Outcome 3 Withdrawals due to adverse events.. .. . Analysis 1.4. Comparison 1 SSRI or SNRI versus placebo, Outcome 4 Number of patients with minor adverse events. Analysis 2.1. Comparison 2 SSRI or SNRI versus another active drug (amitriptyline), Outcome 1 Migraine frequency

Search citation statements

Order By: Relevance

Paper Sections

Select...
53
14
9
3

Citation Types

3
53
0
1

Year Published

Range
2014
2014
2026
2026

Publication Types

Select...
60
8
2
2

Relationship

1
71

Authors

Journals

citations

Cited by 72 publications

(57 citation statements)
references

References 70 publications

3
53
0
1
Order By: Relevance
How this paper cites the one you are viewing
“…Depression (22.8%) and anxiety (13.9%) were the two most common comorbities in our dMIG population in line with the literature (10,43). The high rates of these disorders in our dMIG population may explain the preference for antidepressant use as well as the suggested role of neurotransmitters in development of headache (44).…”
Section: Discussion
supporting
confidence: 86%